Estimation of the complications of the COVID-19 vaccine on the Iraqi population

Abstract

This study aims to the estimation of the complications of the COVID-19 vaccine on the Iraqi population
A retrospective study was conducted in Iraq, where 400 patients with coronavirus who underwent the vaccine were collected from different hospitals, and the patients were divided into two groups (G1 with negative effects for 200 patients and the second group without any effects for 200 patients
this study was designed based on a questionnaire distributed to patients for a period of 27 days (4-5-2021 to 1-6-2021).
The questionnaire distributed to patients was divided into two parts. Where the first part was designed to collect information and demographic data such as age and gender, in addition to comorbidities and the status of infection with sars CoV-2.
As for the second part, which was concerned with the vaccine, in addition to the quantity of doses and the study of the negative effects associated with the Covid 19 vaccine.
In this study, patients were informed of the presence of several complications, including fatigue, which included the most common complications for 160 patients with 80%, followed by fever for 120 patients with 60 patients, and chill for 89 patients with 44.5%.
As for the least prevalent complications in our study, We find the pain at site reaction for 17 patients with 8.5 and loss of sense for ten patients with 5%
and statistically significant relationship was found between the prevalence of these complications with AstraZeneca vaccine more than other vaccines used in this study).